Skip to main content
Top

03-02-2025 | Tuberculosis | Original Article

A Situational Analysis and an Untapped Opportunity for Tackling Challenges Associated with Coverage of Tuberculosis Preventive Treatment: A Multi-Centric Study in India

Authors: Amber Kumar, Akash Ranjan Singh, Praveen Anand, Dhruvendra Pandey, Sarika Gupta, Lalitha K, Inder Puri, BrajRaj S. Gosh, Manjeet Singh Chalga, Manjula Singh, TPT Team

Published in: Indian Journal of Pediatrics

Login to get access

Abstract

Objectives

To assesses the coverage, adherence, reasons for non-initiation and non-completion of tuberculosis preventive treatment (TPT) among household child contacts (HHCC) of pulmonary tuberculosis (TB).

Methods

This cross-sectional study was conducted across eight sites in India. Estimated sample size was 200 per site. Information was collected through record review and house-to-house visits of HHCCs of notified pulmonary TB cases during January to March 2022. Coverage and adherence was assessed by proportion of eligible HHCC initiated and completed TPT, respectively.

Results

Of 2554 HHCCs eligible for TPT, initiation and completion rate was 34% and 22%, respectively. Across the sites the median time to conduct home visit was 14 d (IQR 9, 22) and TPT initiation was 7 d (IQR 1, 21). Reasons for the non-initiation were no information provided by paramedical workers (82%), information provided by paramedical workers but TPT was not given (19%), parents felt it’s not important (9%), and fear of side-effects (3%). Reasons for non-completion were: TPT received for less than six months (from healthcare providers) (54%), advised for the lesser duration TPT by the doctors (4%), parents felt completion was not important (32%), parents’ fear of side-effects or myth (5%), and HHCC complained of side-effect (0.7%).

Conclusions

Inadequate emphasis on home visits leads to TPT initiation in only one-third and completion in less than one-fourth of eligible HHCCs. This poor coverage was primarily due to the health system related issues. Rarely reported TPT side-effects highlighted its safety.
Literature
4.
7.
go back to reference Central TB Division. National Strategic Plan for Tuberculosis Elimination 2017–2025 [Internet]. New Delhi: Central TB Division, Directorate General of Health Services, Ministry of Health with Family Welfare, Nirman Bhavan, New Delhi–110108; 2017. Available at: http://tbcindia.gov.in/WriteReadData/NSP. Accessed on 23 Mar 2024. Central TB Division. National Strategic Plan for Tuberculosis Elimination 2017–2025 [Internet]. New Delhi: Central TB Division, Directorate General of Health Services, Ministry of Health with Family Welfare, Nirman Bhavan, New Delhi–110108; 2017. Available at: http://​tbcindia.​gov.​in/​WriteReadData/​NSP. Accessed on 23 Mar 2024.
9.
go back to reference Pease C, Hutton B, Yazdi F, et al. A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection. Pharmacoepidemiol Drug Saf. 2018;27:557–66.CrossRefPubMed Pease C, Hutton B, Yazdi F, et al. A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection. Pharmacoepidemiol Drug Saf. 2018;27:557–66.CrossRefPubMed
10.
go back to reference Chen CP, Lin YC, Chen TC, et al. A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19). PLoS ONE. 2020;15:e0242763.CrossRefPubMedPubMedCentral Chen CP, Lin YC, Chen TC, et al. A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19). PLoS ONE. 2020;15:e0242763.CrossRefPubMedPubMedCentral
11.
12.
go back to reference Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: A systematic review and meta-analysis. Lancet Infect Dis. 2016;16:1269–78.CrossRefPubMed Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: A systematic review and meta-analysis. Lancet Infect Dis. 2016;16:1269–78.CrossRefPubMed
13.
go back to reference Revised National Tuberculosis Control Programme (RNTCP). Training Modules (1–4) for Programme Managers and Medical Officers. New Delhi; 2020. Available at: www.tbcindia.gov.in. Accessed on 20 Mar 2024. Revised National Tuberculosis Control Programme (RNTCP). Training Modules (1–4) for Programme Managers and Medical Officers. New Delhi; 2020. Available at: www.​tbcindia.​gov.​in. Accessed on 20 Mar 2024.
14.
go back to reference Pothukuchi M, Nagaraja SB, Kelamane S, et al. Tuberculosis contact screening and isoniazid preventive therapy in a South Indian district: operational issues for programmatic consideration. PLoS ONE. 2011;6:e22500.CrossRefPubMedPubMedCentral Pothukuchi M, Nagaraja SB, Kelamane S, et al. Tuberculosis contact screening and isoniazid preventive therapy in a South Indian district: operational issues for programmatic consideration. PLoS ONE. 2011;6:e22500.CrossRefPubMedPubMedCentral
15.
go back to reference Singh AR, Kharate A, Bhat P, et al. Isoniazid preventive therapy among children living with tuberculosis patients: Is it working? A mixed-method study from Bhopal, India. J Trop Pediatr. 2017;63:274–85.PubMed Singh AR, Kharate A, Bhat P, et al. Isoniazid preventive therapy among children living with tuberculosis patients: Is it working? A mixed-method study from Bhopal, India. J Trop Pediatr. 2017;63:274–85.PubMed
16.
go back to reference Rekha B, Jagarajamma K, Chandrasekaran V, Wares F, Sivanandham R, Swaminathan S. Improving screening and chemoprophylaxis among child contacts in India’s RNTCP: A pilot study. Int J Tuberc Lung Dis. 2013;17:163–8.CrossRefPubMed Rekha B, Jagarajamma K, Chandrasekaran V, Wares F, Sivanandham R, Swaminathan S. Improving screening and chemoprophylaxis among child contacts in India’s RNTCP: A pilot study. Int J Tuberc Lung Dis. 2013;17:163–8.CrossRefPubMed
17.
go back to reference Shivaramakrishna HR, Frederick A, Shazia A, et al. Isoniazid preventive treatment in children in two districts of South India: does practice follow policy? Int J Tuberc Lung Dis. 2014;18:919–24.CrossRefPubMed Shivaramakrishna HR, Frederick A, Shazia A, et al. Isoniazid preventive treatment in children in two districts of South India: does practice follow policy? Int J Tuberc Lung Dis. 2014;18:919–24.CrossRefPubMed
18.
go back to reference Khaparde K, Jethani P, Dewan PK, et al. Evaluation of TB case finding through systematic contact investigation, Chhattisgarh, India. Tuberc Res Treat. 2015;2015:670167.PubMedPubMedCentral Khaparde K, Jethani P, Dewan PK, et al. Evaluation of TB case finding through systematic contact investigation, Chhattisgarh, India. Tuberc Res Treat. 2015;2015:670167.PubMedPubMedCentral
19.
go back to reference Paradkar M, Padmapriyadarsini C, Jain D, et al. Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India. PLoS ONE. 2020;15:e0236743.CrossRefPubMedPubMedCentral Paradkar M, Padmapriyadarsini C, Jain D, et al. Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India. PLoS ONE. 2020;15:e0236743.CrossRefPubMedPubMedCentral
20.
go back to reference Dolla CK, Padmapriyadarsini C, Thiruvengadam K, et al. Age-specific prevalence of TB infection among household contacts of pulmonary TB: Is it time for TB preventive therapy? Trans R Soc Trop Med Hyg. 2019;113:632–40.CrossRefPubMedPubMedCentral Dolla CK, Padmapriyadarsini C, Thiruvengadam K, et al. Age-specific prevalence of TB infection among household contacts of pulmonary TB: Is it time for TB preventive therapy? Trans R Soc Trop Med Hyg. 2019;113:632–40.CrossRefPubMedPubMedCentral
21.
go back to reference Chandrasekaran P, Mave V, Thiruvengadam K, et al. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting. PLoS ONE. 2018;13:e0199360.CrossRefPubMedPubMedCentral Chandrasekaran P, Mave V, Thiruvengadam K, et al. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting. PLoS ONE. 2018;13:e0199360.CrossRefPubMedPubMedCentral
22.
go back to reference Singh AR, Shewade HD, Pandey R. Near real-time supervision of home visits for patients with tuberculosis. Int J Tuberc Lung Dis. 2020;24:260–1.CrossRefPubMed Singh AR, Shewade HD, Pandey R. Near real-time supervision of home visits for patients with tuberculosis. Int J Tuberc Lung Dis. 2020;24:260–1.CrossRefPubMed
23.
go back to reference BanuRekha VV, Jagarajamma K, Wares F, Chandrasekaran V, Swaminathan S. Contact screening and chemoprophylaxis in India’s Revised Tuberculosis Control Programme: A situational analysis. Int J Tuberc Lung Dis. 2009;13:1507–12. BanuRekha VV, Jagarajamma K, Wares F, Chandrasekaran V, Swaminathan S. Contact screening and chemoprophylaxis in India’s Revised Tuberculosis Control Programme: A situational analysis. Int J Tuberc Lung Dis. 2009;13:1507–12.
25.
go back to reference Toppo M, Gour D, Singh AR, Shewade HD, Keerthana S, Kamble M. “TB drug stock planning in advance is a futile activity” health system’s perceived challenges and suggested solutions pertaining to Nikshay Aushadhi portal in central India. Indian J Tuberc. 2024;71:395–404.CrossRefPubMed Toppo M, Gour D, Singh AR, Shewade HD, Keerthana S, Kamble M. “TB drug stock planning in advance is a futile activity” health system’s perceived challenges and suggested solutions pertaining to Nikshay Aushadhi portal in central India. Indian J Tuberc. 2024;71:395–404.CrossRefPubMed
Metadata
Title
A Situational Analysis and an Untapped Opportunity for Tackling Challenges Associated with Coverage of Tuberculosis Preventive Treatment: A Multi-Centric Study in India
Authors
Amber Kumar
Akash Ranjan Singh
Praveen Anand
Dhruvendra Pandey
Sarika Gupta
Lalitha K
Inder Puri
BrajRaj S. Gosh
Manjeet Singh Chalga
Manjula Singh
TPT Team
Publication date
03-02-2025
Publisher
Springer India
Published in
Indian Journal of Pediatrics
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-024-05364-y

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Watch now